Breo Ellipta · DIN 02444186 · 200 mcg & 25 mcg · Blister dry-powder inhaler, 30 doses
Limited Use, Reason for Use code 330 requiredMarketed · checked November 18, 2026
StatusLimited Use, Reason for Use code 330 required
Write on scriptReason for Use code 330 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 330
Reason for Use code 330
For the treatment of asthma in patients who are using optimum anti-inflammatory treatment and are still experiencing breakthrough symptoms.
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Breo Ellipta · DIN 02444186
Manufacturer: GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care; listing date 2016-08-30
Health Canada: Marketed since 2015-10-02 · brand BREO ELLIPTA · ATC R03AK10 VILANTEROL AND FLUTICASONE FUROATE · form Powder · route Inhalation · ingredients FLUTICASONE FUROATE 200 MCG/ACT, VILANTEROL (VILANTEROL TRIFENATATE) 25 MCG/ACT · company Glaxosmithkline inc · schedule Prescription
Breo Ellipta: Formulary list price $175.16 per unit (the source does not state the unit; exact figure $175.1600). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02444186)
Source record
DIN 02444186: Breo Ellipta
Raw flags: sec12=Y, sec3=Y
Item: 121200111; group id 225; item number 0403; lccId 00268; manufacturer id GSK
Source form: Blister Pd Inh-30 Dose Pk; strength: 200mcg & 25mcg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $175.1600; ministry $175.1600
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02444186
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=92906
Shortage status: not checked (no credentials)